1. Home
  2. AMPH vs CLMT Comparison

AMPH vs CLMT Comparison

Compare AMPH & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • CLMT
  • Stock Information
  • Founded
  • AMPH 1996
  • CLMT 1916
  • Country
  • AMPH United States
  • CLMT United States
  • Employees
  • AMPH N/A
  • CLMT N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • CLMT Oil & Gas Production
  • Sector
  • AMPH Health Care
  • CLMT Energy
  • Exchange
  • AMPH Nasdaq
  • CLMT Nasdaq
  • Market Cap
  • AMPH 1.1B
  • CLMT 1.3B
  • IPO Year
  • AMPH 2014
  • CLMT 2006
  • Fundamental
  • Price
  • AMPH $21.67
  • CLMT $16.43
  • Analyst Decision
  • AMPH Hold
  • CLMT Strong Buy
  • Analyst Count
  • AMPH 5
  • CLMT 6
  • Target Price
  • AMPH $38.00
  • CLMT $20.17
  • AVG Volume (30 Days)
  • AMPH 462.5K
  • CLMT 723.4K
  • Earning Date
  • AMPH 08-07-2025
  • CLMT 08-08-2025
  • Dividend Yield
  • AMPH N/A
  • CLMT N/A
  • EPS Growth
  • AMPH N/A
  • CLMT N/A
  • EPS
  • AMPH 2.77
  • CLMT N/A
  • Revenue
  • AMPH $730,659,000.00
  • CLMT $4,177,500,000.00
  • Revenue This Year
  • AMPH $0.92
  • CLMT N/A
  • Revenue Next Year
  • AMPH $5.55
  • CLMT N/A
  • P/E Ratio
  • AMPH $7.84
  • CLMT N/A
  • Revenue Growth
  • AMPH 8.05
  • CLMT 0.68
  • 52 Week Low
  • AMPH $20.43
  • CLMT $7.68
  • 52 Week High
  • AMPH $53.96
  • CLMT $25.29
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 41.15
  • CLMT 53.56
  • Support Level
  • AMPH $20.43
  • CLMT $15.40
  • Resistance Level
  • AMPH $22.90
  • CLMT $17.29
  • Average True Range (ATR)
  • AMPH 0.73
  • CLMT 0.71
  • MACD
  • AMPH 0.15
  • CLMT -0.07
  • Stochastic Oscillator
  • AMPH 50.20
  • CLMT 54.50

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About CLMT Calumet Specialty Products Partners L.P. Common Units

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

Share on Social Networks: